Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review

T-cell lymphoma is a rare hematologic malignancy with an incidence rate between 10% and 20% of that of non-Hodgkin lymphomas. Patients with peripheral T-cell lymphoma (PTCL) generally have a poor prognosis when treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP)/CHOP-lik...

Descripción completa

Detalles Bibliográficos
Autores principales: Makita, Shinichi, Maeshima, Akiko Miyagi, Maruyama, Dai, Izutsu, Koji, Tobinai, Kensei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916385/
https://www.ncbi.nlm.nih.gov/pubmed/29719411
http://dx.doi.org/10.2147/OTT.S140756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916385/
https://www.ncbi.nlm.nih.gov/pubmed/29719411
http://dx.doi.org/10.2147/OTT.S140756

Ejemplares similares